Skip Navigation


European Heart Journal Advance Access originally published online on September 25, 2006
European Heart Journal 2006 27(20):2373-2375; doi:10.1093/eurheartj/ehl226
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/20/2373    most recent
ehl226v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Roger, V. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roger, V. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Redefinition of myocardial infarction: new challenges and opportunities

Véronique L. Roger*

Department of Cardiovascular Diseases, 200 First Street, SW, Rochester, MN 55905, USA

* Corresponding author. Tel: +1 507 284 0519; fax: +1 507 266 0228. E-mail address: roger.veronique@mayo.edu

This editorial refers to ‘The effect of correcting for troponins on trends in coronary heart disease events in Finland during 1993–2002: the FINAMI study’{dagger} by V. Salomaa et al., on page 2394

The first 150 words of the full text of this article appear below.

Heart disease is the number one cause of death in the western world and as such constitutes an immense public health problem.1,2 The analysis of the trends in the incidence and outcome of myocardial infarction coupled to that of coronary disease mortality provides crucial insights into the determinants of heart disease, which is essential to its treatment and prevention. For example, in the face of stable incidence trends, a decline in coronary mortality most likely reflects the impact of secondary prevention and medical care, whereas increasing incidence of disease conversely would point to primary prevention. Within this framework, it is important to recognize that the trends in the incidence and outcome of coronary disease are complex, likely multifactorial, and evolve over time. Indeed, as the respective role of these two theoretical determinants varies across person, time, and place, continued surveillance is essential to detect change in the trends and their . . . [Full Text of this Article]

Myocardial infarction as a chief indicator of the burden of heart disease

Assessing the burden of coronary disease when definitions change

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

The effect of correcting for troponins on trends in coronary heart disease events in Finland during 1993–2002: the FINAMI study
Veikko Salomaa, Matti Ketonen, Heli Koukkunen, Pirjo Immonen-Räihä, Aapo Lehtonen, Jorma Torppa, Kari Kuulasmaa, Y. Antero Kesäniemi, Kalevi Pyörälä, and for the FINAMI Study Group
EHJ 2006 27: 2394-2399. [Abstract] [FREE Full Text]